Home

Hasič Pesimistický knihovna event free survival vs overall survival Někdy někdy koruna bufet

When Overall Survival Fails to Confirm Event-Free Survival, Should the  Latter Be Used to Set the Standard of Care? | Journal of Clinical Oncology
When Overall Survival Fails to Confirm Event-Free Survival, Should the Latter Be Used to Set the Standard of Care? | Journal of Clinical Oncology

Event-free survival at 24 months is a robust surrogate endpoint for  long-term survival in pediatric, adolescent, and adult T cell lymphoblastic  lymphoma | SpringerLink
Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma | SpringerLink

Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival  as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal  Adenocarcinoma
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma

Educational Sessions: "Approving new therapies for early breast cancer" -  YouTube
Educational Sessions: "Approving new therapies for early breast cancer" - YouTube

Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology  white paper
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper

OP0294 SJÖGREN'S SYNDROME ASSOCIATED LYMPHOMAS: CLINICAL DESCRIPTION AND  10-YEAR SURVIVAL | Annals of the Rheumatic Diseases
OP0294 SJÖGREN'S SYNDROME ASSOCIATED LYMPHOMAS: CLINICAL DESCRIPTION AND 10-YEAR SURVIVAL | Annals of the Rheumatic Diseases

Survival analysis in hematologic malignancies: recommendations for  clinicians | Haematologica
Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica

Wilms tumour event-free and overall survival in Southern and Eastern  Europe: Pooled analyses of clinical data from four childhood cancer  registries (1999–2017) - ScienceDirect
Wilms tumour event-free and overall survival in Southern and Eastern Europe: Pooled analyses of clinical data from four childhood cancer registries (1999–2017) - ScienceDirect

Worse event-free and relapse-free survival in financially disadvantaged  patients with breast cancer in South India - ScienceDirect
Worse event-free and relapse-free survival in financially disadvantaged patients with breast cancer in South India - ScienceDirect

Event-free and overall survival following neoadjuvant weekly paclitaxel and  dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast.  - ppt download
Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download

Statistical considerations and endpoints for clinical lung cancer studies:  Can progression free survival (PFS) substitute overall survival (OS) as a  valid endpoint in clinical trials for advanced non-small-cell lung cancer?  | Semantic
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic

A) Event-free survival (EFS), (B) disease-free survival (DFS), and (C)... |  Download Scientific Diagram
A) Event-free survival (EFS), (B) disease-free survival (DFS), and (C)... | Download Scientific Diagram

Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know

Cureus | Does Timing of Completion Radical Cholecystectomy Determine the  Survival Outcome in Incidental Carcinoma Gallbladder: A Single-Center  Retrospective Analysis | Article
Cureus | Does Timing of Completion Radical Cholecystectomy Determine the Survival Outcome in Incidental Carcinoma Gallbladder: A Single-Center Retrospective Analysis | Article

Comparisons of recurrence-free survival and overall survival between  microwave versus radiofrequency ablation treatment for hepatocellular  carcinoma: A multiple centers retrospective cohort study with propensity  score matching | PLOS ONE
Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching | PLOS ONE

Cancers | Free Full-Text | Venetoclax in Relapse/Refractory AL  Amyloidosis—A Multicenter International Retrospective Real-World Study
Cancers | Free Full-Text | Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study

Kaplan-Meier curves for (A) event-free survival and (B) | Open-i
Kaplan-Meier curves for (A) event-free survival and (B) | Open-i

Improved Event-Free Survival and Higher Incidence of Early Fever Associated  with Mismatches at HLA-DRB1 after Nonmyeloablative HLA-Haploidentical  Transplantation - Biology of Blood and Marrow Transplantation
Improved Event-Free Survival and Higher Incidence of Early Fever Associated with Mismatches at HLA-DRB1 after Nonmyeloablative HLA-Haploidentical Transplantation - Biology of Blood and Marrow Transplantation

Kaplan-Meier plot of event-free survival (EFS) and overall survival... |  Download Scientific Diagram
Kaplan-Meier plot of event-free survival (EFS) and overall survival... | Download Scientific Diagram

Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know

Association of progression-free or event-free survival with overall survival  in diffuse large B-cell lymphoma after immunochemotherapy: a systematic  review | Leukemia
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia

Early Stage W.H.O. Grade I and II Follicular Lymphoma Treated with  Radiation Therapy Alone | PLOS ONE
Early Stage W.H.O. Grade I and II Follicular Lymphoma Treated with Radiation Therapy Alone | PLOS ONE

Clinical Trial Endpoints for Oncology Studies
Clinical Trial Endpoints for Oncology Studies

Event-free survival > Overall survival? - data analysis - Datamethods  Discussion Forum
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum

Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children |  NEJM
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children | NEJM

Event-free survival (EFS) and overall survival (OS) according to risk... |  Download Scientific Diagram
Event-free survival (EFS) and overall survival (OS) according to risk... | Download Scientific Diagram